Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An aggressive carcinoma that arises from the parotid gland. It is characterized by the presence of malignant epithelial and myoepithelial cells forming cribriform, tubular, and solid patterns. It usually presents as a slow growing mass. Patients develop pain because of the tendency of these carcinomas to invade perineural tissues.
Biomarker and diagnostic research for parotid gland adenoid cystic carcinoma has been reported in the published literature.
No clinical trials have been registered for parotid gland adenoid cystic carcinoma.
54 publications have been identified in PubMed for parotid gland adenoid cystic carcinoma. Research spans Case Report / Case Series (41%), Diagnostic / Biomarker (19%), and Epidemiology / Natural History (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 22 | 41% |
Data assembled from 2 of 12 sources · Last updated Sep 17, 2026, 10:47 PM UTC
Testing and diagnosis research
10 |
19% |
Disease patterns and progression | 6 | 11% |
Research summaries | 5 | 9% |
Other research | 3 | 6% |
Clinical study results | 3 | 6% |
New treatment approaches | 3 | 6% |
Laboratory research | 2 | 4% |
Kominsky E (2026). [PMID: 42037367](https://pubmed.ncbi.nlm.nih.gov/42037367/). *Otolaryngol Head Neck Surg*. [Epidemiology / Natural History]
Martin A (2026). [PMID: 42231931](https://pubmed.ncbi.nlm.nih.gov/42231931/). *Tech Innov Patient Support Radiat Oncol*. [Case Report / Case Series]
Wu X (2026). [PMID: 41585187](https://pubmed.ncbi.nlm.nih.gov/41585187/). *J Dent Sci*. [Review / Meta-Analysis]
Tomasoni M (2026). [PMID: 42090990](https://pubmed.ncbi.nlm.nih.gov/42090990/). *Oral Oncol*. [Diagnostic / Biomarker]
Lametti A (2026). [PMID: 42184085](https://pubmed.ncbi.nlm.nih.gov/42184085/). *Head Neck Pathol*. [Case Report / Case Series]
Kaur K (2026). [PMID: 41841047](https://pubmed.ncbi.nlm.nih.gov/41841047/). *Cureus*. [Case Report / Case Series]
Boschetti CE (2026). [PMID: 42242993](https://pubmed.ncbi.nlm.nih.gov/42242993/). *Int J Oral Maxillofac Surg*. [Diagnostic / Biomarker]
Young A (2026). [PMID: 33079504](https://pubmed.ncbi.nlm.nih.gov/33079504/). *Unknown Journal*. [Review / Meta-Analysis]
Irifune Y (2026). [PMID: 41865703](https://pubmed.ncbi.nlm.nih.gov/41865703/). *Auris Nasus Larynx*. [Diagnostic / Biomarker]
Unknown (2026). [PMID: 42051915](https://pubmed.ncbi.nlm.nih.gov/42051915/). *J Surg Case Rep*. [Other]
AI-curated news mentioning parotid gland adenoid cystic carcinoma
Updated Jun 3, 2026
A population-based study investigates the prognosis of T4b parotid gland squamous cell carcinoma, providing valuable insights into patient outcomes. This research contributes to the understanding of this rare cancer type.